Work

Risk of Venous Thromboembolism in Patients with Resectable Colorectal Cancer According to Stage

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Venous thromboembolism (VTE) is a significant source of morbidity in patients undergoing colectomy and proctectomy for colorectal adenocarcinoma. However, the association between cancer stage and VTE risk is unclear. We aimed to describe the association between colorectal cancer stage and post-operative VTE among patients undergoing resection for colorectal cancer. METHODS: Utilizing the 2022-2023 American College of Surgeons National Surgical Quality Improvement Program database, a retrospective cohort study was conducted. A multivariable logistic regression analyzed the association between VTE and cancer stage with adjustments for covariates. RESULTS: Of 18,830 patients fitting inclusion criteria, 4,418 (23%) had stage I adenocarcinoma, 6,509 (35%) had stage II, 6,402 (34%) had stage III and 1,501 (8%) had stage IV; while 302 (2%) experienced postoperative VTE. On univariate analysis, patients with stage II, III and IV cancers had higher VTE rates than patients with stage I (stage I: 0.9%, stage II: 1.7%, stage III: 1.8%: stage IV 2.5%; p < 0.001). In the multivariable analysis of VTE risk, patients with stage II, III and IV cancer had higher odds of VTE relative to patients with stage I cancer (OR for stage II vs. I: 1.57; 95% confidence interval [CI]: 1.08, 2.27; p = 0.017; OR for stage III vs. I: 1.77; 95% CI: 1.22, 2.55; p = 0.002; OR for stage IV vs. I: 1.73, 95% CI:1.07, 2.79; p = 0.025). CONCLUSION: Resectable colorectal cancers at higher stages are associated with increased risk of VTE. Understanding the differences in risk can help clinicians make more informed and targeted treatment plans for patients undergoing colectomy or proctectomy for locoregional adenocarcinoma.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W7235775038
FWCI:
Cites: 19
Cited by:
Related to: 10